Cardiac Imaging in Childhood Cancer Survivors: A State-of-the-Art Review

Curr Probl Cardiol. 2023 Apr;48(4):101544. doi: 10.1016/j.cpcardiol.2022.101544. Epub 2022 Dec 15.

Abstract

Childhood cancer survival has improved significantly in the past few decades, reaching rates of 80% or more at 5 years. However, with improved survival, early- and late-occurring complications of chemotherapy and radiotherapy exposure are becoming progressively more evident. Cardiovascular diseases represent the leading cause of non-oncological morbidity and mortality in this highly vulnerable population. Therefore, the necessity of reliable, noninvasive screening tools able to early identify cardiac complications early is now pre-eminent in order to implement prevention strategies and mitigate disease progression. Echocardiography, may allow identification of myocardial dysfunction, pericardial complications, and valvular heart diseases. However, additional imaging modalities may be necessary in selected cases. This manuscript provides an in-depth review of noninvasive imaging parameters studied in childhood cancer survivors. Furthermore, we will illustrate brief surveillance recommendations according to available evidence and future perspectives in this expanding field.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents*
  • Cancer Survivors*
  • Child
  • Heart Diseases*
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Survivors

Substances

  • Antineoplastic Agents